| P/E (FY) | — | Sales (TTM) | $428.6M |
| Earnings (TTM) | -$46.1M | ROE | −2.52% |
| Net Margin | −0.35% | ROIC | 0.00% |
| Debt / Equity | 1.68 | TD / EBITDA | 9.76 |
| EPS Growth 3Y | — | Sales Growth 3Y | 2.17% |
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for treating tumors across North America, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife robotic stereotactic radiosurgery system for tumors outside the brain and the TomoTherapy platform, including the Radixact System, which integrates radiation treatment planning, delivery, and data management, along with its iDMS data management system.
| Market Cap | $29.0M | Trading Days | 4894 |
| 52W High | 2.10 |
| 52W Low | 0.22 |
| % Off High | −88.41% |
| YTD | −70.32% | 1Y | −82.49% |
| 3Y | −94.20% | 5Y | −94.13% |
| 10Y | −95.56% | Since incept. (ann.) | −21.70% |
Europe India Middle East And Africa 31% · CN 27% · Americas 19% · JP 12% · …
| Ann. Volatility (1Y) | 100.73% | Ann. Volatility (3Y) | 84.12% |
| Sharpe (1Y) | −1.23 | Sharpe (3Y) | −0.70 |
| Max Drawdown (1Y) | −87.84% | Max Drawdown (3Y) | −94.72% |
| Beta (3Y, vs SPY) | 2.06 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| BEAT | HeartBeam, Inc. | $29.3M | — |
| TELA | TELA Bio, Inc. | $30.0M | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $27.3M | — |
| NSPR | InspireMD, Inc. | $32.1M | — |
| PETV | PetVivo Holdings, Inc. | $24.1M | — |
| CTSO | Cytosorbents Corp | $23.2M | — |
| MCAG | Mountain Crest Acquisition Corp. V | $38.1M | — |
| PAVM | PAVmed Inc. | $39.1M | — |
| RVP | RETRACTABLE TECHNOLOGIES INC | $20.1M | — |
| AURX | Nuo Therapeutics, Inc. | $43.6M | — |
| SRTS | Sensus Healthcare, Inc. | $48.4M |
| — |
| MDAI | Spectral AI, Inc. | $49.6M | — |
